APA
Nickel M., Simonati A., Jacoby D., Lezius S., Kilian D., Van de Graaf B., Pagovich O. E., Kosofsky B., Yohay K., Downs M., Slasor P., Ajayi T., Crystal R. G., Kohlschütter A., Sondhi D. & Schulz A. (20191016). Disease characteristics and progression in patients with late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease: an observational cohort study. : The Lancet. Child & adolescent health.
Chicago
Nickel Miriam, Simonati Alessandro, Jacoby David, Lezius Susanne, Kilian Dirk, Van de Graaf Benjamin, Pagovich Odelya E, Kosofsky Barry, Yohay Kaleb, Downs Matthew, Slasor Peter, Ajayi Temitayo, Crystal Ronald G, Kohlschütter Alfried, Sondhi Dolan and Schulz Angela. 20191016. Disease characteristics and progression in patients with late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease: an observational cohort study. : The Lancet. Child & adolescent health.
Harvard
Nickel M., Simonati A., Jacoby D., Lezius S., Kilian D., Van de Graaf B., Pagovich O. E., Kosofsky B., Yohay K., Downs M., Slasor P., Ajayi T., Crystal R. G., Kohlschütter A., Sondhi D. and Schulz A. (20191016). Disease characteristics and progression in patients with late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease: an observational cohort study. : The Lancet. Child & adolescent health.
MLA
Nickel Miriam, Simonati Alessandro, Jacoby David, Lezius Susanne, Kilian Dirk, Van de Graaf Benjamin, Pagovich Odelya E, Kosofsky Barry, Yohay Kaleb, Downs Matthew, Slasor Peter, Ajayi Temitayo, Crystal Ronald G, Kohlschütter Alfried, Sondhi Dolan and Schulz Angela. Disease characteristics and progression in patients with late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease: an observational cohort study. : The Lancet. Child & adolescent health. 20191016.